Advertisement
Singapore markets close in 6 hours 31 minutes

  • Straits Times Index

    3,271.35
    -21.78 (-0.66%)
     

  • Nikkei

    37,777.63
    -682.45 (-1.77%)
     

  • Hang Seng

    17,282.28
    +81.01 (+0.47%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    64,268.30
    -2,346.05 (-3.52%)
     

  • CMC Crypto 200

    1,387.26
    -36.84 (-2.59%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,331.50
    -6.90 (-0.30%)
     

  • Crude Oil

    82.72
    -0.09 (-0.11%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,571.43
    -0.05 (-0.00%)
     

  • Jakarta Composite Index

    7,159.03
    -15.50 (-0.22%)
     

  • PSE Index

    6,582.47
    +9.72 (+0.15%)
     

Oncolytics Biotech (ONCY) Looks Strong: Stock Up 21.9%

Zacks Equity Research


Oncolytics Biotech Inc. (ONCY) was a big mover last session, as the company saw its shares surge nearly 22% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 75.4% in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Oncolytics Biotech currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other players in the healthcare industry include Illumina (ILMN), Medivation, Inc. (MDVN) and Merrimack Pharmaceuticals, Inc. (MACK) all carrying the same Zacks Rank as Oncolytics Biotech.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ONCOLYTICS BIOTECH INC (ONCY): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

MEDIVATION INC (MDVN): Free Stock Analysis Report

MERRIMACK PHARMACEUTICALS INC (MACK): Free Stock Analysis Report


Zacks Investment Research